The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...

A study using Ribo-STAMP technology reveals that protein production in brain cells varies significantly between different types of neurons, offering new insights into autism and memory.

Researchers applied the Ribo-STAMP method to map protein translation in nearly 20,000 mouse hippocampal cells. The study ...

A potential massive breakthrough!

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

Therapeutic mRNA delivered via lipid nanoparticles restored sperm production in genetically infertile mice and produced live ...

The study involved 550 healthy U.S. adults ages 18 to 75 who received either the experimental combo vaccine and a placebo or ...

This week, vaccine manufacturer Moderna revealed that Vinaya Prasad, the top vaccine regulator at the Food and Drug Administration (FDA)—which is a part of HHS— declined to even consider the safety ...

Successful PAT implementation should start small, with the goal of integrating data into decision-making and fostering cross-functional collaboration.

Healthcare social media content gathered by MedPage Today staff ...